ERBB2 and breast carcinoma: Transcriptomic analysis further evidenced additional heterogeneity among breast cancers, and a total of five major subgroups are identified based on RNA expression profiles, namely, luminal A, luminal B, HER2-enriched, low claudin, and basal-like [6,7].